Skip to main content
. 2022 Mar 14;13:819861. doi: 10.3389/fphar.2022.819861

TABLE 3.

Network meta-analysis results 5 weeks after stem cell therapy.

ADMSCs
0.23 (−1.52, 1.92) BMSCs
1.06 (−0.76, 2.90) 0.84 (−0.30, 2.00) NSCs
3.74 (2.12, 5.27) 3.50 (2.84, 4.18) 2.66 (1.74, 3.58) Placebo
0.20 (−1.72, 2.09) −0.03 (−1.42, 1.32) −0.86 (−2.36, 0.58) −3.53 (−4.72, −2.35) UCMSCs